Abstract
Studies of human Nijmegen breakage syndrome (NBS) cells have led to the proposal that the Mre11/Rad50/ NBS1 complex, which is involved in the repair of DNA double-strand breaks (DSBs), might also function in activating the DNA damage checkpoint pathways after DSBs occur1,2. We have studied the role of the homologous budding yeast complex, Mre11/Rad50/Xrs2, in checkpoint activation in response to DSB-inducing agents. Here we show that this complex is required for phosphorylation and activation of the Rad53 and Chk1 checkpoint kinases specifically in response to DSBs. Consistent with defective Rad53 activation, we observed defective cell-cycle delays after induction of DSBs in the absence of Mre11. Furthermore, after γ-irradiation phosphorylation of Rad9, which is an early event in checkpoint activation, is also dependent on Mre11. All three components of the Mre11/Rad50/Xrs2 complex are required for activation of Rad53, however, the Ku80, Rad51 or Rad52 proteins, which are also involved in DSB repair, are not. Thus, the integrity of the Mre11/Rad50/Xrs2 complex is specifically required for checkpoint activation after the formation of DSBs.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Haber, J. E. Cell 95, 583–586 (1998).
Petrini, J. Am. J. Hum. Genet. 64, 1264–1269 (1999).
Sanchez, Y. et al. Science 271, 357–360 (1996).
Sun, Z., Fay, D. S., Marini, F., Foiani, M. & Stern, D. F. Genes Dev. 10, 395–406 (1996).
de la Torre-Ruiz, M.-A., Green, C. M. & Lowndes, N. F. EMBO J. 17, 2687–2698 (1998).
Pellicioli, A. et al. EMBO J. 18, 6561–6572 (1999).
Paulovich, A. G. & Hartwell, L. H. Cell 82, 841–847 (1995).
Aboussekhra, A. et al. EMBO J. 15, 3912–3922 (1996).
Sanchez, Y. et al. Science 286, 1166–1171 (1999).
Emili, A. Mol. Cell 2, 183–189 (1998).
Vialard, J. E., Gilbert, C. S., Green, C. M. & Lowndes, N. F. EMBO J. 17, 5679–5688 (1998).
Longhese, M. P. et al. EMBO J. 16, 5216–5226 (1997).
Paciotti, V., Lucchini, G., Plevani, P. & Longhese, M. P. EMBO J. 17, 4199–4209 (1998).
Paciotti, V., Clerici, M., Lucchini, G. & Longhese, M. P. Genes Dev. 14, 2046–2059 (2000).
Weinert, T. Curr. Opin. Genet. Dev. 8, 185–193 (1998).
Lowndes, N. F. & Murguia, J. R. Curr. Opin. Genet. Dev. 10, 17–25 (2000).
Usui, T. et al. Cell 95, 705–716 (1998).
Nelms, B. E., Maser, R. S., Mackay, J. F., Lagally, M. G. & Petrini, J. H. Science 280, 590–590 (1998).
Neecke, H., Lucchini, G. & Longhese, M. P. EMBO J. 18, 4485–4497 (1999).
Carney, J. P. et al. Cell 93, 477–486 (1998).
Stewart, G. S. et al. Cell 99, 577–587. (1999).
Matsuura, K. et al. Biochem. Biophys. Res. Commun. 242, 602–607 (1998).
Yamazaki, V., Wegner, R.-D. & Kirchgessner, C. U. Cancer Res. 58, 2316–2322 (1998).
Antoccia, A. et al. Int. J. Radiat. Biol. 75, 583–591 (1999).
Girard, P. et al. Cancer Res. 60, 4881–4888 (2000).
Antoccia, A., Ricordy, R., Maraschio, P., Prudente, S. & Tanzarella, C. Int. J. Radiat. Biol. 71, 41–49 (1997).
Pincheira, J., Bravo, M. & Santos, M. Clin. Genet. 53, 262–267 (1998).
Xiao, Y. & Weaver, D. T. Nucleic Acids Res. 25, 2985–2991 (1997).
Luo, G. et al. Proc. Natl Acad. Sci. USA 96, 7376–7381 (1999).
Zhu, J., Petersen, S., Tessarollo, L. & Nussenzweig, A. Curr. Biol. 11, 105–109 (2001).
Acknowledgements
We thank J. Diffley, S. Jackson and M. P. Longhese for yeast strains and plasmids; A. Verreault, S. Jackson and S. West for critical reading of the manuscript. We are indebted to C. Green and J. Murguia for many stimulating discussions. We also thank B. Sedgewick and A. Verreault for their generosity. M.G. was supported in part by La Ligue Nationale contre le Cancer, Paris.
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Supplementary figures and comments
Figure S1 MRE11-dependent phosphorylation of Rad53 (PDF 144 kb)
Figure S2 Ddc2/Lcd1 and Ddc1 are phosphorylated in mre11Δ cells in the absence of DNA damaging agents.
Comment on supplementary results.
Rights and permissions
About this article
Cite this article
Grenon, M., Gilbert, C. & Lowndes, N. Checkpoint activation in response to double-strand breaks requires the Mre11/Rad50/Xrs2 complex. Nat Cell Biol 3, 844–847 (2001). https://doi.org/10.1038/ncb0901-844
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/ncb0901-844
This article is cited by
-
Antiviral immunity and nucleic acid sensing in haematopoietic stem cell gene engineering
Gene Therapy (2021)
-
DNA double-strand breaks: linking gene expression to chromosome morphology and mobility
Chromosoma (2014)
-
Initiation of DNA damage responses through XPG-related nucleases
The EMBO Journal (2012)
-
Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma
BMC Medical Genetics (2009)
-
Meiotic localization of Mre11 and Rad50 in wild type, spo11-1, and MRN complex mutants of Coprinus cinereus
Chromosoma (2009)